About
Inflarx N.v. — investor relations, events, news, and company updates on 6ix.
Latest News
Yesterday
InflaRx Announces Pricing of $150 Million Underwritten Offering of Ordinary Shares
May 4 2026
InflaRx Reports Favorable Reactive Metabolite Profile for Izicopan in Human Liver Microsomes
May 1 2026
InflaRx to Report First Quarter 2026 Results on May 7, 2026
Apr 9 2026
InflaRx Reports New Mechanistic Data for Izicopan Supporting its Potential as a Best-in-Class C5aR Inhibitor
Mar 31 2026
InflaRx Announces Participation in the Raymond James 2026 Biotech Innovation Symposium
Recent Videos

IFRX STOCK : RANGE BREAKOUT | INFLARX STOCK
Apr 30, 2026

Michelle Medovich from InflaRx on forming new vendor relationships on her own
Mar 31, 2026

InflaRx (IFRX|$54.2M) - 2025 Full Year Earnings Analysis
Mar 20, 2026

IFRX STOCK : RANGE BREAKOUT | INFLARX STOCK
Dec 16, 2025
Google Übersetzer